Immune reconstitution and clinical outcomes in B-ALL patients with versus without pre-HSCT Immunotherapy - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Immune Recovery and Clinical Outcomes After HSCT in B-ALL Patients With or Without Prior Immunotherapy

  • By

  • Yu-Yuan Zeng

  • Guan-Hua Hu

  • Ying-Xi Zuo

  • Pan Suo

  • Lu Bai

  • Feng Zhang

  • Hui-Fang Wang

  • Ying-Jun Chang

  • Meng Lv

  • Xiao-Hui Zhang

  • Yu Wang

  • Lan-Ping Xu

  • Xiao-Jun Huang

  • Lin Wang

  • Yi-Fei Cheng

  • October 21, 2026

Share

Original Source(s)

Immune reconstitution and clinical outcomes in B-ALL patients with versus without pre-HSCT Immunotherapy

  • by Yu-Yuan Zeng, Guan-Hua Hu, Ying-Xi Zuo, Pan Suo, Lu Bai, Feng Zhang, Hui-Fang Wang, Ying-Jun Chang, Meng Lv, Xiao-Hui Zhang, Yu Wang, Lan-Ping Xu, Xiao-Jun Huang, Lin Wang, Yi-Fei Cheng

  • October 21, 2026

Related Content

Stereotactic body radiation therapy in elderly patients with spinal metastases

Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region

Personalized Breast Cancer Screening: Moving Beyond Age-Based Algorithms

Breast cancer screening has traditionally been organized around two principal variables: when mammography should begin and how frequently it should be performed.

  • by

  • October 16, 2026

  • 7 min